Gyros Protein Technologies (Gyros AB Merged With Protein Technologies)
Dag Hammarskjolds väg 54
Uppsala Science Park
Uppsala
SE-75183
Tel: 46-0-18-566-300
Fax: 46-0-18-566-350
Website: http://www.gyros.com/
Email: info@gyros.com
58 articles about Gyros Protein Technologies (Gyros AB Merged With Protein Technologies)
-
Gyros Protein Technologies and Biotage partner to advance peptide purification efficiency with new automated solution
12/7/2023
Gyros Protein Technologies AB and Biotage announced a partnership to offer Biotage® PeptiPEC, based on Gyros’ PurePep® EasyClean catch and release technology, on Biotage® Extrahera™ automated sample preparation system.
-
Gyros Protein Technologies Introduces PurePep EasyClean Auto Kit for Automated Parallel Peptide Purification
7/27/2023
Gyros Protein Technologies AB announced the launch of its PurePep® EasyClean Auto Kit for the automated parallel purification of peptides, accelerating downstream processes for research, development, and production of simple to complex peptide drugs and therapies.
-
Gyros Protein Technologies Adds Gyrolab® Biomarker Kits to Expand Range of Ready-to-Use Kits and Reagents
11/29/2022
Gyros Protein Technologies AB, a leading provider of peptide synthesizers and reagents and a pioneer in automated nanoliter-scale immunoassays, introduced Gyrolab® Human Cytokine Kit Reagents, the first in a range of new biomarker kits.
-
Gyros Protein Technologies introduces PurePep Sonata+ peptide synthesizer
3/2/2022
Gyros Protein Technologies AB, a leading provider of peptide synthesizers and reagents and a pioneer in automated nanoliter-scale immunoassays, announced the launch of PurePep® Sonata®+, a mid-pilot scale peptide synthesizer.
-
Biopharma and life sciences companies from around the globe provide updates on their businesses and pipelines.
-
Gyros Protein Technologies and Cygnus Technologies Expand Collaboration to Support Improved Bioprocess Impurity Analytics, and Introduce HEK 293 HCP Assay Reagent Set for Gyrolab
7/7/2021
Collaboration is poised to deliver a range of ready-to-use bioprocess impurity reagent sets optimized for use with the Gyrolab platform
-
Gyros Protein Technologies Introduces Gyrolab AAVX Titer Kit to Support Cell and Gene Therapy Market
9/2/2020
Ready-to-use kit enables rapid adeno-associated virus titer determinations during the manufacture of AAV vectors
-
Mesa Labs Acquires Gyros Protein Technologies
11/1/2019
Mesa Laboratories, Inc., a diversified supplier of quality control instruments and consumables to highly regulated markets announced the acquisition of Gyros Protein Technologies Holding AB
-
BioSpace Global Roundup, Sept. 12
9/12/2019
Companies and organizations from across Europe, Asia and North America share updates on their business and pipelines. -
Gyros Protein Technologies introduces Gyrolab p24 Kit to support the cell and gene therapy market
9/9/2019
Ready-to-use kit enables lentivirus titer determinations during the manufacture of lentivirus vectors
-
BioSpace Global Roundup, Sept. 5
9/5/2019
Companies from across Europe and Asia share updates on their business and pipelines. -
Gyros Protein Technologies introduces PurePep Chorus automated peptide synthesizer
9/4/2019
Flexible, modular system, designed for 21CFR Part 11 compliance
-
Gyros Protein Technologies Introduces Gyrolab CHO-HCP E3G Kit for Impurity Testing of Biotherapeutics
8/13/2018
Gyros Protein Technologies AB today introduced Gyrolab® CHO-HCP E3G Kit for impurity analysis in the CMC (chemistry manufacturing and controls).
-
Gyros Protein Technologies and Cygnus Technologies Sign Licensing and Supply Agreement
7/10/2018
Gyros Protein Technologies to develop immunoassay kits for biotherapeutic impurity analysis using Cygnus Technologies’ proprietary reagents
-
Gyros Protein Technologies Introduces Gyrolab xPand to Improve Immunoassay Workflow, Flexibility and Speed in Biotherapeutic Discovery, Development and Production
3/19/2018
New 5 CD platform combines Gyrolab immunoassay technology with expanded software to optimize time to results and sample capacity while simplifying workflows; Gyrolab xPand will be showcased on March 19-22 at BPI West in San Francisco and April 9-13 at WRIB in Philadelphia
-
Gyros Protein Technologies Introduces Multi-Species Kit for Toxicokinetic Studies
1/16/2018
The new Gyrolab Generic TK Kit adds to a growing menu of ready-to-use kits, and allows researchers to more efficiently quantify human therapeutic antibodies (IgG) in automated, nanoliter-scale Gyrolab xP and Gyrolab xPlore systems.
-
Gyros Protein Technologies Signs Distribution Agreement With Euro Diagnostica
10/11/2017
-
Gyros Protein Technologies Introduces New ADA Solution For Immunogenicity Market
6/29/2017
-
Gyros Protein Technologies Introduces Next Generation Gyrolab Protein A Kit For Biotherapeutics
5/10/2017
-
Gyros Protein Technologies Appoints Mark Vossenaar As Vice President, European Sales
5/4/2017